In this study, we found that the protective mechanism of ibrutinib against viral- and bacterial-induced ALI involves the regulation of the BTK-, FLT3-, and EGFR-related signaling pathways and the suppression of inflammatory factors. This evidence concerns the gene BTK and acute respiratory distress syndrome.